O’Donnell, Patricio http://orcid.org/0000-0001-7788-624X
Dijkstra, Francis M.
Damar, Ugur
Quanhong, Lei
de Goede, Annika A. http://orcid.org/0000-0002-1549-6753
Xu, Lin
Pascual-Leone, Andres http://orcid.org/0000-0002-9429-1683
Buhl, Derek L. http://orcid.org/0000-0003-4433-7150
Zuiker, Rob http://orcid.org/0000-0001-5604-0157
Ruijs, Titia Q.
Heuberger, Jules A. A. C. http://orcid.org/0000-0001-7202-5088
MacMullin, Paul
Lubell, Martin
Asgharnejad, Mahnaz
Murthy, Venkatesha
Rotenberg, Alexander
Jacobs, Gabriel E.
Rosen, Laura
Article History
Received: 20 November 2020
Revised: 5 April 2021
Accepted: 12 May 2021
First Online: 27 May 2021
Conflict of interest
: P.O., L.Q., D.L.B., M.L., M.A., V.M., and L.R. are employees of Takeda Pharmaceuticals; L.X. was employed by Takeda at the time of the study; F.M.D., A.A.dG., R.Z., T.Q.R., J.A.A.C.H., and G.E.J. are employees of the Centre for Human Drug Research. A.R. received financial support related to TMS from NIH NIMH, NIH NINDS, CURE, Epilepsy Foundation, Boston Children’s Hospital Translational Research Program, Massachusetts Life Sciences, BrainsWay, Kintai, Roche, and Takeda. He has served on scientific advisory boards or consulted for Cavion, NeuroRex, Otsuka, and Roche. He has received charitable contributions to his research from the Assimon family, Fisher family, and Sestito family. A.R. is co-founder and/or on the scientific advisory boards of Neuromotion, Gamify, and Epihunter. In addition, A.R. is an inventor on patent 9,849,300 T.M.S. methods and apparatus. U.D., A.P.L., and P.M. have no competing interests to declare.